Merck cervical cancer vaccine prevents lesions
NEW YORK (Reuters) - An experimental Merck & Co. vaccine completely prevented early-stage cervical cancer and precancerous cervical lesions caused by the two most common forms of a virus linked to such cancers, Merck said on Thursday.
Continue to Merck cervical cancer vaccine prevents lesions on Reuters Health eLine.
Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz
